Skip to main content
NVDA+0.44%AAPL+0.63%MSFT+0.08%GOOGL+0.84%AMZN+0.89%TSM+1.82%SPCX+1.97%META-0.87%AVGO+2.81%TSLA+2.57%LLY+0.62%BRK-B-0.84%MU+2.08%SKHY+1.25%WMT-0.76%JPM+0.49%AMD+3.73%XOM-1.17%V-0.93%JNJ+0.53%ASMLa+1.43%MA-0.79%ABBV-0.27%INTC+2.34%CVX-1.15%1398.HK+2.15%0700.HK-0.31%COST-0.82%CSCO+0.42%KO-0.32%ORCL+3.27%PG-0.45%UNH+0.39%1816.HK+1.32%BAC+0.11%3988.HK+0.66%HD-0.32%CAT+2.05%0857.HK-0.98%PM+0.58%0939.HK+0.81%AP2d+0.27%AMAT+0.47%1288.HK+0.60%GE+1.93%LRCX-0.05%DELL+5.75%0005.HK-5.56%HSBA.L-6.01%NVS+0.92%NZDMXN+0.69%EURSEK-0.65%NZDJPY+0.63%AUDJPY+0.61%USDJPY+0.57%EURNZD-0.56%AUDDKK+0.54%EURZAR-0.54%EURAUD-0.53%CHFSEK-0.49%EURUSD-0.49%NZDCHF+0.47%AUDCHF+0.47%GBPZAR-0.44%GBPNZD-0.42%USDSEK-0.42%GBPAUD-0.42%GBPTRY+0.41%USDCHF+0.41%GBPUSD-0.37%CADJPY+0.37%NZDSGD+0.34%GBPHKD+0.32%EURNOK-0.31%USDMXN+0.30%USDZAR-0.30%EURCNH-0.29%EURSGD-0.29%GBPMXN-0.28%EURCAD-0.26%NZDCAD+0.26%AUDSGD+0.26%EURHKD-0.25%AUDCAD+0.24%USDDKK+0.23%AUDNOK+0.23%NOKJPY+0.23%USDCAD+0.21%SGDJPY+0.21%CADCHF+0.20%GBPSGD-0.19%GBPJPY+0.19%GBPCAD-0.18%USDTRY+0.18%CHFJPY+0.17%USDILS+0.16%CHFNOK-0.14%EURPLN-0.13%USDTHB-0.13%CHFSGD-0.12%EURGBP-0.11%USDPLN+0.10%EURCHF-0.09%EURJPY+0.09%USDNOK-0.07%NZDUSD+0.06%PLNJPY+0.06%EURCZK-0.05%USDSGD-0.05%AUDUSD+0.05%USDCNH-0.05%USDCOP-0.04%USDHKD+0.03%GBPCHF+0.02%AUDNZD-0.02%EURDKK0.00%COFFEE-3.21%HG1+1.32%XNGUSD-0.96%UKOIL-0.88%USOIL-0.85%XAUUSD+0.83%GAUUSD+0.82%COTTON-0.70%XAGUSD+0.53%GAGUSD+0.53%S1-0.46%C1-0.41%BTCUSD+0.30%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+3.87%DOGEUSD+20.65%XMRUSDT-0.92%LINKUSD+25.58%BCHUSDT+2.51%XLMUSD-0.40%UNIUSD-0.21%LTCUSD+17.89%SUIUSD+0.27%HBARUSDT-1.53%TONUSD+41.71%TAOUSDT-0.44%AAVEUSD-2.85%DOTUSDT-2.08%ICPUSDT-1.98%ONDOUSDT-0.07%WLDUSDT-1.24%ARBUSDT-0.13%JUPUSDT-0.06%INJUSDT-0.16%ATOMUSDT-0.82%STXUSDT-1.40%TIAUSDT-3.08%PYTHUSDT-3.10%FETUSDT+1.81%SEIUSDT+0.54%IMXUSDT-0.66%GRTUSDT-0.27%OPUSDT-1.09%IOTAUSDT+0.54%WIFUSDT-1.72%POLUSDT-1.15%AXSUSDT+0.20%EOSUSDT+0.86%FARTCOINUSDT+1.98%DYDXUSDT+0.66%GALAUSDT-1.33%ORDIUSDT+0.99%RONINUSDT+0.02%NOTUSDT+1.92%NVDA+0.44%AAPL+0.63%MSFT+0.08%GOOGL+0.84%AMZN+0.89%TSM+1.82%SPCX+1.97%META-0.87%AVGO+2.81%TSLA+2.57%LLY+0.62%BRK-B-0.84%MU+2.08%SKHY+1.25%WMT-0.76%JPM+0.49%AMD+3.73%XOM-1.17%V-0.93%JNJ+0.53%ASMLa+1.43%MA-0.79%ABBV-0.27%INTC+2.34%CVX-1.15%1398.HK+2.15%0700.HK-0.31%COST-0.82%CSCO+0.42%KO-0.32%ORCL+3.27%PG-0.45%UNH+0.39%1816.HK+1.32%BAC+0.11%3988.HK+0.66%HD-0.32%CAT+2.05%0857.HK-0.98%PM+0.58%0939.HK+0.81%AP2d+0.27%AMAT+0.47%1288.HK+0.60%GE+1.93%LRCX-0.05%DELL+5.75%0005.HK-5.56%HSBA.L-6.01%NVS+0.92%NZDMXN+0.69%EURSEK-0.65%NZDJPY+0.63%AUDJPY+0.61%USDJPY+0.57%EURNZD-0.56%AUDDKK+0.54%EURZAR-0.54%EURAUD-0.53%CHFSEK-0.49%EURUSD-0.49%NZDCHF+0.47%AUDCHF+0.47%GBPZAR-0.44%GBPNZD-0.42%USDSEK-0.42%GBPAUD-0.42%GBPTRY+0.41%USDCHF+0.41%GBPUSD-0.37%CADJPY+0.37%NZDSGD+0.34%GBPHKD+0.32%EURNOK-0.31%USDMXN+0.30%USDZAR-0.30%EURCNH-0.29%EURSGD-0.29%GBPMXN-0.28%EURCAD-0.26%NZDCAD+0.26%AUDSGD+0.26%EURHKD-0.25%AUDCAD+0.24%USDDKK+0.23%AUDNOK+0.23%NOKJPY+0.23%USDCAD+0.21%SGDJPY+0.21%CADCHF+0.20%GBPSGD-0.19%GBPJPY+0.19%GBPCAD-0.18%USDTRY+0.18%CHFJPY+0.17%USDILS+0.16%CHFNOK-0.14%EURPLN-0.13%USDTHB-0.13%CHFSGD-0.12%EURGBP-0.11%USDPLN+0.10%EURCHF-0.09%EURJPY+0.09%USDNOK-0.07%NZDUSD+0.06%PLNJPY+0.06%EURCZK-0.05%USDSGD-0.05%AUDUSD+0.05%USDCNH-0.05%USDCOP-0.04%USDHKD+0.03%GBPCHF+0.02%AUDNZD-0.02%EURDKK0.00%COFFEE-3.21%HG1+1.32%XNGUSD-0.96%UKOIL-0.88%USOIL-0.85%XAUUSD+0.83%GAUUSD+0.82%COTTON-0.70%XAGUSD+0.53%GAGUSD+0.53%S1-0.46%C1-0.41%BTCUSD+0.30%ETHUSD+23.96%USDTUSD+0.03%XRPUSD+14.74%SOLUSD+17.47%TRXUSDT-0.15%ZECUSDT+3.87%DOGEUSD+20.65%XMRUSDT-0.92%LINKUSD+25.58%BCHUSDT+2.51%XLMUSD-0.40%UNIUSD-0.21%LTCUSD+17.89%SUIUSD+0.27%HBARUSDT-1.53%TONUSD+41.71%TAOUSDT-0.44%AAVEUSD-2.85%DOTUSDT-2.08%ICPUSDT-1.98%ONDOUSDT-0.07%WLDUSDT-1.24%ARBUSDT-0.13%JUPUSDT-0.06%INJUSDT-0.16%ATOMUSDT-0.82%STXUSDT-1.40%TIAUSDT-3.08%PYTHUSDT-3.10%FETUSDT+1.81%SEIUSDT+0.54%IMXUSDT-0.66%GRTUSDT-0.27%OPUSDT-1.09%IOTAUSDT+0.54%WIFUSDT-1.72%POLUSDT-1.15%AXSUSDT+0.20%EOSUSDT+0.86%FARTCOINUSDT+1.98%DYDXUSDT+0.66%GALAUSDT-1.33%ORDIUSDT+0.99%RONINUSDT+0.02%NOTUSDT+1.92%
OP

OptimizeRx Corp. (OPRX)

NASDAQ • Healthcare

$9.07
-$0.08 (-0.9%)
Market open

Last close at October 26, 2026 at 20:00 UTC

Open$9.15
Previous Close$9.07
Day Range$8.93 - $9.25
Avg. Volume (3M)156K
Market Cap$170.8M
P/E Ratio37.8
52 Week Range
$4.54$21.56
Next EarningsIn 9 daysNov 5, 2026

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$20.5M100%
Gross Profitminus cost of goods$15.6M77%

In plain terms: out of every $100 in revenue, OptimizeRx Corp. currently loses $3.

Fundamentals & Financials

Revenue (TTM)
$98.6M
Net Income (TTM)
$4.6M
EPS (TTM)
$0.24
ROA (TTM)
2.8%
Current Ratio
5.58
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

+121.7%Q1 2026$0.51
+1300.0%Q2 2026$0.14
+44.0%Q3 2026$0.16
Next

Nov 5

in 9 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Beat +44.0%

OptimizeRx topped consensus on both the top and bottom line in the second fiscal quarter of 2026, based on preliminary results reported August 12, 2026, with adjusted EPS of $0.16 topping the $0.11 estimate (+44%) and revenue of $20.5 million topping the $20.2 million estimate (+1.5%). Revenue fell 29.8% year over year to about $20.5 million (down from roughly $29.2 million a year ago), reflecting the quarter’s performance in its digital health messaging and workflow tools delivered through electronic health records. Gross profit came in around $15.7 million, with gross margin at about 77%. Adjusted EPS declined 33.3% year over year to $0.16 (down from $0.24 a year ago), while operating cash flow was about $8.6 million. For the next period, consensus calls for EPS of $0.19 on revenue of $21.6 million.

Next report — what to expect

OptimizeRx Corp. (OPRX) reports earnings on November 5, 2026. Wall Street is looking for EPS of $0.18 on revenue of $21.2 million. For trailing context, revenue fell -29.8% year over year last quarter. OptimizeRx has beaten EPS in 8 of its 8 most recent quarters, making consistency a key watchpoint.

View full earnings history

About OptimizeRx Corp.

OptimizeRx Corp. trades on NASDAQ under the ticker OPRX and operates in healthcare information services, supplying digital communications tools that connect drug makers and care teams inside clinical software. The company generated $109.4 million in FY2025 revenue through messaging and workflow products delivered through electronic health records.

Name
OptimizeRx Corp.
CEO
Stephen L. Silvestro
Industry
Healthcare
Year Founded
2006
Employees
133

Today's Snapshot

AI-generated

The session opened with OPRX slightly higher at 9.11, while its sector was flat. OptimizeRx partnered with PulsePoint, a healthcare advertising platform, to expand access to its healthcare-professional media. OPRX reports earnings on 5 November.

Trading Volume

Below 10d avg (118.8K)

24.5K

vs S&P 500 Today

Outperforming Market

+0.81%

Updated: October 27, 2026 at 14:38 UTC

Technical Indicators

6 Buy2 Neutral0 Sell
OPRX presents a strong buy profile underpinned by a firm trend and constructive momentum while volatility remains subdued. ADX near 28 signals a healthy trend, MACD and CCI are positive, and the price sits above short‑ and medium‑term moving averages and comfortably above the 200‑day average, though the classic pivot is close. ATR is modest at roughly 5%, and OBV signals accumulation despite a large negative nominal figure. These elements combine to show trend and volume alignment in the near term. Technical takeaway: Strong Buy, with trend and volume supporting current strength.
All signals
  • EMA (5 indicators)$7.78 - $8.89
    Buy
  • RSI (14)60.69
    Neutral
  • Stochastic %K (14, 3, 3)66.44
    Neutral
  • MACD Level (12, 26)0.32
    Buy
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.